Europe · News · Reuters

Gate Bioscience expands Lilly drug discovery deal worth more than $870 million

Published by Reuters · United Kingdom 9 h ago

Gate Bioscience said on Monday it expanded a research and licensing agreement with Eli Lilly to develop ‌treatments targeting disease-causing proteins, in a deal potentially…

Read the full article on Reuters Sign in to save

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.reuters.com)

Also worth reading

Metro

Giant Qing porcelain dish worth £30,000 that was made for Beijing's Forbidden City is found under family's sofa in north London home

Evening Standard

What went wrong at telecoms group TalkTalk?

The Guardian

Gate Bioscience expands Lilly drug discovery deal worth more than $870 million

Share

Also worth reading

Girl, 12, killed in crossfire after ‘parking space row’ turns deadly

Pedro Sánchez has lost control of the narrative. So he's calling an election

Ikea to close 3 of its smaller format stores – here are the locations leaving

Giant Qing porcelain dish worth £30,000 that was made for Beijing's Forbidden City is found under family's sofa in north London home

What went wrong at telecoms group TalkTalk?

Nobu chef killed by teen driver who crashed into his parked car in Malibu